Financial statements Neupharm
Balance sheet of Neupharm
Company age:
Age:
8 y. 1 m. 10 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of NEUPHARM
|
Year
|
2017
|
2019
|
2020
|
2022
|
|---|---|---|---|---|
| Total assets | 10 677,63 | 9 891,48 | 5 785,32 | 6 605,00 |
| A. Fixed assets | 3 000,00 | 3 000,00 | 3 000,00 | 3 000,00 |
| B. Current assets | 7 677,63 | 6 891,48 | 2 785,32 | 3 605,00 |
| C. Share capital contributions (basic funds) | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - |
| Total liabilities | 10 677,63 | 9 891,48 | 5 785,32 | 6 605,00 |
| A. Equity | 1 896,87 | 4 595,09 | 5 185,32 | -10 471,18 |
| B. Liabilities and provisions for liabilities | 8 780,76 | 5 296,39 | 600,00 | 17 076,18 |
| I. Long-term liabilities | - | - | - | - |
| II. Short-term liabilities | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.